11-77189343-G-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000260.4(MYO7A):c.3504-1G>C variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,613,086 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000260.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.3504-1G>C | splice_acceptor_variant, intron_variant | Intron 27 of 48 | 1 | NM_000260.4 | ENSP00000386331.3 | |||
MYO7A | ENST00000458637.6 | c.3504-1G>C | splice_acceptor_variant, intron_variant | Intron 27 of 48 | 1 | ENSP00000392185.2 | ||||
MYO7A | ENST00000409619.6 | c.3471-1G>C | splice_acceptor_variant, intron_variant | Intron 28 of 49 | 1 | ENSP00000386635.2 | ||||
MYO7A | ENST00000458169.2 | c.1047-1G>C | splice_acceptor_variant, intron_variant | Intron 7 of 28 | 1 | ENSP00000417017.2 | ||||
MYO7A | ENST00000670577.1 | n.1344-1G>C | splice_acceptor_variant, intron_variant | Intron 10 of 31 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000403 AC: 1AN: 248446Hom.: 0 AF XY: 0.00000741 AC XY: 1AN XY: 134986
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460932Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726782
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152154Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74320
ClinVar
Submissions by phenotype
not provided Pathogenic:2
This sequence change affects an acceptor splice site in intron 27 of the MYO7A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is present in population databases (no rsID available, gnomAD 0.0009%). Disruption of this splice site has been observed in individual(s) with Usher syndrome (PMID: 15660226, 24199935, 28559085). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as IVS27-1G>C. ClinVar contains an entry for this variant (Variation ID: 554480). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Identified in patients with suspected MYO7A-related disorders in published literature (PMID: 28559085, 15660226, 22135276); Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9718356, 28559085, 31964843, 15660226, 22135276, 24199935, 23770805) -
Usher syndrome type 1;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
- -
Usher syndrome type 1;C1832475:Autosomal dominant nonsyndromic hearing loss 11;C1838701:Autosomal recessive nonsyndromic hearing loss 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at